{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:53:24Z","timestamp":1793084004451,"version":"4.5.0"},"reference-count":31,"publisher":"Wiley","issue":"18","license":[{"start":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T00:00:00Z","timestamp":1464652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2016,9,15]]},"abstract":"<jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>Although urine\u2010based testing for human papillomavirus (HPV) is being explored as a practical approach for cervical cancer screening, whether the results differ by age, race, or indicators of excess body weight or in populations exposed to HPV vaccines has not been documented by previous studies. The purpose of this study was to determine the accuracy of urinary HPV testing for the presence of cervical HPVs and high\u2010grade cervical intraepithelial lesions (grade 2 and 3 cervical intraepithelial neoplasia [CIN]) by the aforementioned population characteristics.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>The study population consisted of 502 women diagnosed with different grades of CIN. HPV testing was performed with paired urine and cervical cell DNA with the Roche Diagnostics Linear Array test. Agreement coefficient 1 and probabilities were calculated to determine the accuracy of urinary HPV testing for the presence of cervical HPVs and CIN lesions.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Substantial to almost perfect agreement (0.66\u20100.83) was observed in the detection of any HPV genotype in urine specimens versus cervical specimens, regardless of the population characteristics. Although the positive predictive value for the detection of CIN lesions was relatively low, the negative predictive value for CIN\u20103 was high (\u226590%) among women positive for any of the urinary or cervical high\u2010risk human papillomavirus (HR\u2010HPV) genotypes or HPV genotypes not included in currently available HPV vaccines.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>The results demonstrate that urinary HPV testing provides highly satisfactory results for excluding the possibility of any cervical HPV infections, including HPV types not included in vaccines and CIN lesions associated with any HR\u2010HPV, regardless of a woman's age, race, or excess body weight. <jats:bold><jats:italic>Cancer<\/jats:italic> 2016.<\/jats:bold> \u00a9 <jats:italic>2016 American Cancer Society<\/jats:italic>. <jats:italic><jats:bold>Cancer 2016;122:2836\u20132844.<\/jats:bold> \u00a9 2016 American Cancer Society<\/jats:italic><\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.30123","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T11:01:33Z","timestamp":1464692493000},"page":"2836-2844","source":"Crossref","is-referenced-by-count":21,"title":["Accuracy of urinary human papillomavirus testing for the presence of cervical human papillomaviruses and higher grades of cervical intraepithelial neoplasia"],"prefix":"10.1002","volume":"122","author":[{"given":"Chandrika J.","family":"Piyathilake","sequence":"first","affiliation":[{"name":"Department of Nutrition Sciences University of Alabama at Birmingham Birmingham Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguna","family":"Badiga","sequence":"additional","affiliation":[{"name":"Department of Nutrition Sciences University of Alabama at Birmingham Birmingham Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Chambers","sequence":"additional","affiliation":[{"name":"Department of Nutrition Sciences University of Alabama at Birmingham Birmingham Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilene K.","family":"Brill","sequence":"additional","affiliation":[{"name":"Department of Epidemiology University of Alabama at Birmingham Birmingham Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Matthews","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Morehouse School of Medicine Atlanta Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward E.","family":"Partridge","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center University of Alabama at Birmingham Birmingham Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,5,31]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.6.506"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F"},{"key":"e_1_2_8_4_1","first-page":"1","article-title":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses","volume":"90","year":"2007","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.11.796"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.12.958"},{"key":"e_1_2_8_7_1","volume-title":"Excess Cervical Cancer Mortality: A Marker for Low Access to Health Care in Poor Communities","author":"Freeman H","year":"2005"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2007.06.007"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bodyim.2012.11.003"},{"key":"e_1_2_8_10_1","first-page":"81","article-title":"Medical care for obese patients: advice for health care professionals","volume":"65","author":"National Task Force on the Prevention and Treatment of Obesity","year":"2002","journal-title":"Am Fam Physician"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-108X(199604)19:3<275::AID-EAT6>3.0.CO;2-J"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g5264"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.12.032"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1348\/000711006X126600"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/0470011815.b2a04024"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"e_1_2_8_17_1","volume-title":"United States Cancer Statistics: 1999\u20102012 Incidence and Mortality Web\u2010Based Report","author":"US Cancer Statistics Working Group","year":"2015"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1258\/jms.2009.009073"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-015-0524-5"},{"key":"e_1_2_8_20_1","first-page":"129","article-title":"Barriers and facilitators of cervical cancer screening among Hispanic women","volume":"17","author":"Byrd TL","year":"2007","journal-title":"Ethn Dis"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62218-7"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018435522475"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050132"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji115"},{"key":"e_1_2_8_25_1","first-page":"1004","article-title":"Vital signs: cervical cancer incidence, mortality, and screening\u2014United States, 2007\u20102012","volume":"63","author":"Benard VB","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6532(09)70069-1"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7262.2007.00287.x"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2015.05.001"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2014.12.022"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-014-2147-2"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2015.11.005"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01623-13"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.30123","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.30123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T09:00:18Z","timestamp":1760259618000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.30123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,31]]},"references-count":31,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2016,9,15]]}},"alternative-id":["10.1002\/cncr.30123"],"URL":"https:\/\/doi.org\/10.1002\/cncr.30123","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,31]]}}}